ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma

ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma

Bo Zhang,1,* Bomiao Cui,1,* Jintao Du,2 Xin Shen,1 Kun Wang,1 Jiao Chen,1 Liying Xiao,1 Chongkui Sun,1 Yan Li1 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China; 2Departm...

Celý popis

Podrobná bibliografie
Hlavní autoři: Zhang B, Cui B, Du J, Shen X, Wang K, Chen J, Xiao L, Sun C, Li Y
Médium: Článek
Jazyk:English
Vydáno: Dove Medical Press 2019-01-01
Edice:Cancer Management and Research
Témata:
ATR
EBV
NPC
chemotherapy resistance
cisplatin
5-fluorouracil
On-line přístup:https://www.dovepress.com/atr-activated-by-eb-virus-facilitates-chemotherapy-resistance-to-cispl-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/atr-activated-by-eb-virus-facilitates-chemotherapy-resistance-to-cispl-peer-reviewed-article-CMAR

Podobné jednotky